Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2000
10/19/2000WO2000060953A2 Methods for stabilizing liquid nutritional products and products so stabilized
10/19/2000WO2000049991A3 Treatment of trauma
10/19/2000WO2000042992A3 Compositions and methods for mucosal delivery
10/19/2000WO2000039290A8 Pharmaceutical formulation containing a microbial enzyme which digests hyaluronic acid
10/19/2000WO2000038620A3 A composition useful to treat periodontal disease
10/19/2000WO2000035484A3 Methods and compositions for decreasing allergic reactions to surface allergens
10/19/2000WO2000035420A3 Stable surgical irrigating solutions
10/19/2000WO2000034308A3 Protein transduction system and methods of use thereof
10/19/2000WO2000033823A3 Methods of using temozolomide in the treatment of cancers
10/19/2000WO2000032224A3 Calcitonin for the modulation of sperm function
10/19/2000WO2000023022A8 Method and compositions for in situ formation of protective and/or medicated films on body tissue
10/19/2000CA2372078A1 Treatment of intracellular infection
10/19/2000CA2369976A1 The novel antisense-oligos with better stability and antisense effect
10/19/2000CA2369684A1 Novel method of treatment
10/19/2000CA2369472A1 Novel medical use of alpha-1-acidic glycoprotein (aag or orosomucoid)
10/19/2000CA2369263A1 Methods and compositions for enhancing delivery of therapeutic agents to tissues
10/19/2000CA2369262A1 Pulmonary administration of dry powder formulations for treating infertility
10/19/2000CA2369225A1 S-hydroxynefazodone
10/19/2000CA2369200A1 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
10/19/2000CA2369084A1 Compounds useful in reducing the level of insulin like growth factor-1 (igf-1) in blood
10/19/2000CA2369029A1 Poly(dipeptide) as a drug carrier
10/19/2000CA2369012A1 Preparations for percutaneous absorption
10/19/2000CA2368655A1 Dry formulation for transcutaneous immunization
10/19/2000CA2367490A1 Iontophoresis device
10/19/2000CA2364659A1 A pharmaceutical formulation comprising an bisphosphonate and an additive agent providing an enhanced absorption of the bisphosphonate
10/19/2000CA2364562A1 Composition for the preservation of infectious recombinant adenoviruses
10/19/2000CA2364556A1 Liquid dispersion polymer compositions, their preparation and their use
10/18/2000EP1045000A1 Cellulose ether films
10/18/2000EP1044693A1 Bioresorbable polymeric clayey and sticky substance
10/18/2000EP1044692A1 Process and device for dry application of products to inhalable powdery supports
10/18/2000EP1044688A1 Method for solubilizing pyridonecarboxylic acid, solubilizer therefor, aqueous solution preparations containing pyridonecarboxylic acid and process for producing the same
10/18/2000EP1044687A1 Powders containing tocotrienols, process for producing the same and tablets prepared by compression molding the same
10/18/2000EP1044686A1 Alcoholic coloured chlorhexidine solution and its manufacturing process
10/18/2000EP1044684A2 Percutaneously absorbable preparation
10/18/2000EP1044683A1 One-step dispersion method for the microencapsulation of water soluble substances
10/18/2000EP1044682A1 Process for producing hard capsule
10/18/2000EP1044681A2 Sustained release carbamazepine formulation
10/18/2000EP1044680A1 Novel method of treatment using a high dosage regimen of amoxycillin and potassium clavulanate
10/18/2000EP1044679A1 Liposomes
10/18/2000EP1044678A1 Lacrimal gland specific emulsions for topical application to ocular tissue
10/18/2000EP1044197A2 New piperidinyl-substituted pyridylalkane, alkene and alkine carboxamides
10/18/2000EP1044143A1 Kits containing cyanoacrylate compositions comprising an antimicrobial agent
10/18/2000EP1044064A2 Device for coating granules to be administered orally
10/18/2000EP1044035A2 Methods, systems, and kits for intravascular nucleic acid delivery
10/18/2000EP1044021A1 Enhanced transport using membrane disruptive agents
10/18/2000EP1044017A1 Supplement for dialysis patients
10/18/2000EP1044015A1 Formulations for amylin agonist peptides
10/18/2000EP1044011A1 Pharmaceutical composition having antitumor activity and process for the preparation thereof
10/18/2000EP1044009A2 Methods and compositions employing red rice fermentation products
10/18/2000EP1044005A1 1,2,4-benzotriazine oxides formulations
10/18/2000EP1043997A1 A dried or frozen pharmaceutical preparation containing a class iii antiarrhythmic compound
10/18/2000EP1043992A2 $i(R)-PROCYCLIDINE FOR TREATING URINARY INCONTINENCE
10/18/2000EP1043985A1 Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
10/18/2000EP1043984A1 Pharmaceutical compositions containing bupropion hydrochloride and an inorganic acid stabilizer
10/18/2000EP1043983A1 Tetracycline and/or tetracycline derivative(s) for treating, suppressing and preventing of cerebrovascular diseases of nervous system
10/18/2000EP1043979A1 Compositions for the transdermal and dermal administration of biologically active agents
10/18/2000EP1043978A1 Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use
10/18/2000EP1043977A1 Oral pharmaceutical pulsed release dosage form
10/18/2000EP1043976A1 Oral pharmaceutical extended release dosage form
10/18/2000EP1043975A1 Magnetically responsive composition
10/18/2000EP1043974A1 Liposomes containing multiple branch peptide constructions for use against human immunodeficiency virus
10/18/2000EP1043973A1 Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant
10/18/2000EP1043941A1 Revitalisation formulation
10/18/2000EP1043937A1 Method of controlling release of antimicrobial agents in chewing gum and gum produced thereby
10/18/2000EP0921793B1 Solid, non-deliquescent formulations of sodium valproate
10/18/2000EP0828507A4 Method for treatment of pain
10/18/2000EP0827513A4 Methods of treatment and diagnostic visualisation, particularly in cancer
10/18/2000EP0750492B1 Inhalation composition containing lactose pellets
10/18/2000EP0648112B1 Precipitation of one or more active compounds in situ
10/18/2000EP0639053B1 New frozen comestibles and method of making same
10/18/2000CN2401182Y Medicinal plaster for cleaning anus and protecting pudendum
10/18/2000CN1270529A Pharmaceutical compositions containing plasma protein
10/18/2000CN1270527A Use of neurotoxin therapy for treatment of urologic and related disorders
10/18/2000CN1270523A Compositions for lubricating and separating tissues and biological membranes
10/18/2000CN1270516A Pharmaceutical preparation comprising colodronate as active ingredient and silicified microcrystalline cellulose as excipient
10/18/2000CN1270515A Methods and compositions for treating pulmonary disorders using optically pure(S)-salmeterol
10/18/2000CN1270514A Pharmaceutical composition for treating dymenorrhea and premature labor
10/18/2000CN1270060A Enteric insulin capsule for treating diabetes
10/18/2000CN1270055A Medical capsule for treating bone rheumatism and preparing process
10/18/2000CN1270044A Process for preparing single-prescription solid Chinese medicine
10/18/2000CN1270039A Chewing tablets of pilose antler, deerhorn and deer bone and preparing process thereof
10/18/2000CN1270037A Powdered Chinese medicine and its preparing process
10/18/2000CN1270033A Gel composition for treating pulmonary tuberculosis cavity difficult to cure it
10/18/2000CN1270032A Ultrasonic concentration-difference acid-alkali method for preparing doxorubicin hydrochloride lipid as injection
10/18/2000CN1270031A Oral liquid of sodium fructose-biphosphate and preparing process thereof
10/18/2000CN1270030A Process for preparing high-purity phosphatide particles directly from concentrated phosphatide
10/18/2000CN1270029A Thebaic analgesic with controllable releasement of active content
10/18/2000CN1270028A Analgesic with controlled releasement of active content
10/18/2000CN1270027A Stable aqueous solution of phthalylglutamic acidimide derivative
10/18/2000CN1270026A Controlled releasing Qumaduo preparation having stably releasing mode and preparing method thereof
10/18/2000CN1270025A Method for preparing pills containing 90 wt.% activated pharmaceutical compositions
10/18/2000CN1270019A Nano-size emulsion containing alkoxyalkenyl or glucose alkoxyalkenyl succinate and uses in cosmetics and pharmaceutics
10/18/2000CN1270011A Water-proof air-permeable plaster for curing wound and its preparing process
10/18/2000CN1057459C Nutritive liquid for male
10/18/2000CN1057456C Wind-dispelling ointment and preparation method thereof
10/18/2000CN1057453C Tongniaoling for diuresis
10/18/2000CN1057452C Pellet for generation of semen
10/18/2000CN1057443C Method for preparing antiviral medicinal compositions
10/18/2000CN1057442C Preparing method for composition pharmaceutique for parenteral injection
10/17/2000US6133327 Which when sprayed forms a sherbet-like solid comprises a concentrate of a lower alcohol and higher alcohol of at least 12 carbons; and a propellant containing dimethyl ester; cooling effect for relief of itching, pain
1 ... 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 2464 ... 2991